Evaluation of polygenic determinants of non-alcoholic fatty liver disease (nafld) by a candidate genes resequencing strategy

HIGHLIGHTS

• who: Alessia Di Costanzo from the We studied , Caucasian, unrelated subjects, with echographically defined NAFLD and , healthy controlsThe enrollment criteria as well as the protocol for clinical and biochemical characterization of study subjects have been reported elsewhere43. In brief, NAFLD subjects, were considered eligible after exclusion of secondary causes of liver steatosis such as previous viral infection, past or present history of alcohol abuse (defined as an average daily consumption >, g/day), use of drugs known to influence the development of hepatic steatosis as well as clinical and biochemical evidence of chronic liver diseases. Healthy controls, recruited . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.